Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Glycinate vs Metformin Hydrochloride in Type 2 Diabetes
NCT01386671Phase 3Completed
- Sponsor
- Laboratorios Silanes
- Start
- Jun 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Metformin glycinate in type 2 diabetes mellitus (T2DM), sponsored by Laboratorios Silanes. Primary endpoint: Glycosylated hemoglobin at 12 months. Started Jun 2014; status: completed.
02
Drugs
Metformin glycinate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01386671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386671.